New scans aim to predict deadly blood cancer before it strikes
NCT ID NCT01237054
Summary
This study aimed to see if new types of medical scans could better detect when early, pre-cancerous blood conditions progress to full multiple myeloma, a serious blood cancer. Researchers compared three different imaging techniques in 31 people diagnosed with either the early conditions or active myeloma. The goal was to gather knowledge to help predict future cancer risk, not to provide treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.